오피오이드 시장 규모, 점유율 및 성장 분석 : 처방 오피오이드별, 시판약 오피오이드별, 남용 방지 제제별, 오피오이드 의존증 치료별, 지역별 - 업계 예측(2026-2033년)

Global Opioids Market size was valued at USD 1.2 Billion in 2024 and is poised to grow from USD 1.25 Billion in 2025 to USD 1.77 Billion by 2033, growing at a CAGR of 4.4% during the forecast period (2026-2033).

The global opioids market is primarily driven by the clinical need for effective pain management in both acute and chronic conditions, influenced by pharmaceutical innovation and evolving regulatory environments. Initially focused on prescription analgesics, market growth surged due to aggressive marketing and relaxed prescribing norms, but tighter regulations have since led to a rise in the use of illicit substances, including synthetic opioids. Current market dynamics are significantly shaped by regulatory and public health responses, spurring innovation, including abuse-deterrent formulations and non-opioid alternatives. The increasing shortage of prescription opioids has intensified the trafficking of synthetic variants, leading to higher overdose rates and growing demand for addiction treatment. Moreover, AI is enhancing surveillance and detection of misuse by analyzing diverse data sources, facilitating proactive interventions and improving market efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Opioids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Opioids Market Segments Analysis

Global opioids market is segmented by prescription opioids, over-the-counter opioids, abuse deterrent formulations, opioid dependency therapies and region. Based on prescription opioids, the market is segmented into Short-acting Opioids and Long-acting Opioids. Based on over-the-counter opioids, the market is segmented into Combination Products and Single Agent Products. Based on abuse deterrent formulations, the market is segmented into Intended for Pain Management and Non-therapeutic Use Prevention. Based on opioid dependency therapies, the market is segmented into Buprenorphine Products and Naltrexone Products. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Opioids Market

The rising prevalence of individuals suffering from chronic pain has significantly boosted the demand for effective pain management solutions, particularly opioids. Healthcare professionals often turn to opioids for treating moderate to severe pain when other treatment options fall short or are not readily available, thereby strengthening prescribing trends and pharmacy inventories. Furthermore, patients advocate for relief from their symptoms, while clinicians strive to enhance quality of life, ensuring ongoing reliance on these medications. This continual clinical necessity encourages pharmaceutical companies to innovate and expand their opioid offerings, further fueling consistent growth in the global opioids market.

Restraints in the Global Opioids Market

The global opioids market faces significant restraints due to stringent regulatory oversight and thorough prescription monitoring programs that restrict the prescribing of opioids, hindering market expansion. Increased regulatory scrutiny drives healthcare providers to exercise greater caution, enhance patient assessment protocols, and opt for non-opioid therapies whenever possible, resulting in diminished initiation of opioid treatments. Furthermore, the demands for risk management strategies and post-marketing surveillance complicate the development process and extend the time required for product introduction, discouraging some manufacturers from expanding their opioid offerings. Collectively, these regulatory challenges limit product availability and reduce prescribing frequency, ultimately slowing the market's overall growth.

Market Trends of the Global Opioids Market

The Global Opioids market is witnessing a significant transformation as the industry pivots towards alternative pain management strategies aimed at minimizing dependence on traditional opioid therapies. There is a marked increase in the development and integration of multimodal pain management regimens that encompass combination therapies and non-opioid pharmacologics, alongside physical and behavioral health interventions. This shift is largely driven by a collective focus from payers and healthcare providers on safety, enhanced patient functionality, and improved long-term recovery outcomes. Pharmaceutical manufacturers are responding by diversifying their portfolios, investing in adjunctive pain agents, and fostering collaborations with specialty clinicians to ensure broader adoption and reimbursement for these comprehensive pain management solutions across various care environments.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Opioids Market Size by Prescription Opioids & CAGR (2026-2033)

• Market Overview
• Short-acting Opioids
• Long-acting Opioids

Global Opioids Market Size by Over-the-Counter Opioids & CAGR (2026-2033)

• Market Overview
• Combination Products
  • Acetaminophen & Opioids
  • Ibuprofen & Opioids
• Single Agent Products
  • Codeine
  • Dihydrocodeine

Global Opioids Market Size by Abuse Deterrent Formulations & CAGR (2026-2033)

• Market Overview
• Intended for Pain Management
• Non-therapeutic Use Prevention

Global Opioids Market Size by Opioid Dependency Therapies & CAGR (2026-2033)

• Market Overview
• Buprenorphine Products
• Naltrexone Products

Global Opioids Market Size & CAGR (2026-2033)

• North America (Prescription Opioids, Over-the-Counter Opioids, Abuse Deterrent Formulations, Opioid Dependency Therapies)
  • US
  • Canada
• Europe (Prescription Opioids, Over-the-Counter Opioids, Abuse Deterrent Formulations, Opioid Dependency Therapies)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Prescription Opioids, Over-the-Counter Opioids, Abuse Deterrent Formulations, Opioid Dependency Therapies)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Prescription Opioids, Over-the-Counter Opioids, Abuse Deterrent Formulations, Opioid Dependency Therapies)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Prescription Opioids, Over-the-Counter Opioids, Abuse Deterrent Formulations, Opioid Dependency Therapies)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Purdue Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcelRx Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grunenthal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorrento Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cara Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collegium Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations